x

Coronavirus

Libya Has Received More Than 57,000 Doses of AstraZeneca Vaccine

CAIRO — Libya has received more than 57,000 doses of a COVID-19 vaccine from the COVAX initiative.

The U.N. children’s agency, UNICEF, said the doses that arrived late Thursday have been earmarked to health workers, people older than 75 and people with chronic disease.

Libya’s National Center for Disease Control said 57,600 doses of the Oxford AstraZeneca vaccine were in the first COVAX shipment to Libya.

On Sunday, Libya received 101,250 doses of the Russian-made Sputnik V vaccine.

Libya has seen swelling COVID-19 cases. The county of around 7 million people has reported more than 166,000 confirmed cases and 2,799 virus-related deaths since the start of the pandemic. However, the actual numbers, like elsewhere in the world, are thought to be far higher.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.

Video

Mitsotakis Meets with Biden at the White House (Video)

WASHINGTON, DC – Greek Prime Minister Kyriakos Mitsotakis met with US President Joe Biden at the White House on Monday, in the first day of an official two-day visit to the American capital.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.